SEARCH RESULTS

169337 RESULTS

MEDI1814

THERAPEUTICS AstraZeneca Immunotherapy (passive) Amyloid-Related In February 2014, AstraZeneca started a multicenter phase 1 trial in the U.S., which is to enroll 242 people with mild to moderate Alzheimer's disease. The study will evaluate single and multiple ...

LY3002813

THERAPEUTICS Eli Lilly & Co. N3pG-amyloid-beta Monoclonal Antibody Immunotherapy (passive) Amyloid-Related In May 2013, Lilly started a phase 1 study in 100 people on the spectrum of mild cognitive impairment due to Alzheimer's disease to mild Alzheimer' ...

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE